AbCellera Biologics stock is trading inside a triangle pattern and testing the key support at 3.90–4.00.
Signals are showing that sellers are losing momentum: CCI prints a bullish divergence and the volume profile highlights accumulation above the current level. A breakout above the descending trendline around 4.30 could open the way towards 4.80 and even 5.60.
From a fundamental perspective the company remains an important biotech player focusing on antibody-based drug development. The sector is highly news driven and any announcement on trials or partnerships could trigger sharp moves.
As long as support holds buyers keep the advantage and the market looks like a spring that has been compressed too long and is ready to release.
Signals are showing that sellers are losing momentum: CCI prints a bullish divergence and the volume profile highlights accumulation above the current level. A breakout above the descending trendline around 4.30 could open the way towards 4.80 and even 5.60.
From a fundamental perspective the company remains an important biotech player focusing on antibody-based drug development. The sector is highly news driven and any announcement on trials or partnerships could trigger sharp moves.
As long as support holds buyers keep the advantage and the market looks like a spring that has been compressed too long and is ready to release.
免責事項
これらの情報および投稿は、TradingViewが提供または承認する金融、投資、取引、またはその他の種類の助言もしくは推奨であることを意図したものではなく、またこれらに該当するものでもありません。詳細は利用規約をご覧ください。
免責事項
これらの情報および投稿は、TradingViewが提供または承認する金融、投資、取引、またはその他の種類の助言もしくは推奨であることを意図したものではなく、またこれらに該当するものでもありません。詳細は利用規約をご覧ください。